USA - Liberty All-Star Equity Fund

NYSE - NYSE Delayed Price. Currency in USD
6.15
+0.08 (+1.32%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close6.02
Open6.13
Bid0.00 x 1100
Ask6.15 x 3100
Day's Range6.11 - 6.18
52 Week Range4.90 - 6.87
Volume902,165
Avg. Volume704,341
Market Cap1.259B
Beta (3Y Monthly)1.27
PE Ratio (TTM)N/A
EPS (TTM)-0.29
Earnings DateN/A
Forward Dividend & Yield0.68 (11.20%)
Ex-Dividend Date2018-04-26
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Liberty All-Star® Equity Fund July 2019 Monthly Update

    BOSTON, Aug. 14, 2019 -- Below is the July 2019 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity Fund.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. July 2019 Monthly Update

    BOSTON, Aug. 14, 2019 -- Below is the July 2019 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG) Liberty All-Star Growth Fund,.

  • GlobeNewswire

    Liberty All-Star® Equity Fund June 2019 Monthly Update

    BOSTON, July 17, 2019 -- Below is the June 2019 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity Fund.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. June 2019 Monthly Update

    BOSTON, July 17, 2019 -- Below is the June 2019 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG).

  • Business Wire

    Liberty All-Star® Equity Fund Declares Distribution

    The Board of Trustees of Liberty All-Star Equity Fund (USA) has declared a distribution of $0.17 per share payable on September 9, 2019 to shareholders of record on July 26, 2019 (ex-dividend date of July 25, 2019). This distribution is in accordance with the Fund’s current distribution policy of paying distributions on its shares totaling approximately 10 percent of its net asset value per year, payable in four quarterly installments of 2.5 percent. The distribution will be paid in newly issued shares to all shareholders except those who are not participating in Liberty All-Star Equity Fund’s Dividend Reinvestment Plan and who elect to receive the distribution in cash.

  • GlobeNewswire

    Liberty All-Star® Equity Fund May 2019 Monthly Update

    BOSTON, June 19, 2019 -- Below is the May 2019 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity FundTicker: USA    Monthly Update, May,.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. May 2019 Monthly Update

    BOSTON, June 19, 2019 -- Below is the May 2019 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG) Liberty All-Star Growth Fund, Inc.Ticker: ASGMonthly.

  • GlobeNewswire

    Liberty All-Star® Equity Fund April 2019 Monthly Update

    BOSTON, May 16, 2019 -- Below is the April 2019 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity Fund.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. April 2019 Monthly Update

    BOSTON, May 16, 2019 -- Below is the April 2019 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG).

  • Benzinga

    Are Closed-End Funds Getting Hot Again?

    Long before the rise of exchange-traded funds , closed-end funds were mutual funds that traded on exchanges alongside stocks. In fact, CEFs date back all the way to the late 19th century. CEFs are similar ...

  • GlobeNewswire

    Liberty All-Star® Equity Fund March 2019 Monthly Update

    BOSTON, April 18, 2019 -- Below is the March 2019 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. March 2019 Monthly Update

    BOSTON, April 18, 2019 -- Below is the March 2019 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG) Liberty All-Star Growth Fund, Inc.Ticker: ASGMonthly.

  • CNW Group

    Medison Issues Letter to Shareholders of Knight Therapeutics, Outlining Qualified, Independent Director Nominees and Common-Sense Plan to Build Value

    PETACH TIKVA, Israel , April 16, 2019 /CNW/ - Medison Biotech (1995) Ltd. ("Medison"), which together with its affiliates owns more than 10.4 million shares or 7.3% of Knight Therapeutics, Inc. (GUD.TO) ("Knight" or the "Company"), today issued an open letter to Knight shareholders.  Included below, the letter provides an overview of Medison's highly qualified, independent director nominees and its common-sense, low-risk plan to build long-term value for the Company and its shareholders. "Knight has a tremendous opportunity to create shareholder value and save patient lives, which is exactly what we've successfully done with Medison in Israel ," said Meir Jakobsohn, CEO of Medison.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. February 2019 Monthly Update

    BOSTON, March 18, 2019 -- Below is the February 2019 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG) Liberty All-Star Growth Fund, Inc.Ticker: ASGMonthly.

  • GlobeNewswire

    Liberty All-Star® Equity Fund February 2019 Monthly Update

    BOSTON, March 18, 2019 -- Below is the February 2019 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity.

  • GlobeNewswire

    Liberty All-Star® Growth Fund, Inc. January 2019 Monthly Update

    BOSTON, Feb. 16, 2019 -- Below is the January 2019 Monthly Update for the Liberty All-Star® Growth Fund, Inc. (NYSE: ASG)     Liberty All-Star Growth Fund Monthly.

  • GlobeNewswire

    Liberty All-Star® Equity Fund January 2019 Monthly Update

    BOSTON, Feb. 16, 2019 -- Below is the January 2019 Monthly Update for the Liberty All-Star® Equity Fund. (NYSE: USA) Liberty All-Star Equity Fund Monthly Update  Ticker:.

  • The 10 Best Closed-End Funds (CEFs) for 2019
    Kiplinger

    The 10 Best Closed-End Funds (CEFs) for 2019

    Closed-end funds (CEFs) joined the rest of the market in steeply selling off late last year. The result, however, was an excessive selloff resulting in greater distribution rates and larger discounts to the assets they hold. The question now is: Which CEFs are ripe for the picking in 2019? "Interesting" is perhaps too nice a word for 2018, but that's still exactly what it was. Corporate America delivered multiyear-best earnings growth for several quarters. Yet we still saw two massive corrections that lifted volatility much closer to its long-term average after several years of relative calm. But what will 2019 hold? The outlook is mixed. While market analysts broadly see GDP growth slowing in 2019, most of those same analysts also see the broader markets heading higher by year's end. Wages are growing, unemployment remains low and there are plenty of other potential drivers for a rally. But if more of the bearish drivers peek through - GDP growth slows even more than expected, tariff tensions linger, etc. - investors will need protection, including high dividends to offset the lack of price gains. With that said, here are the best CEFs to buy for 2019. You can learn more about closed-end funds in detail here, but in short, these are funds that trade on exchange like ETFs, but have some differences; for instance, they can trade at significant discounts or premiums to the assets they hold, and they are actively managed more often than not. These 10 CEFs boast a number of perks, including deep value, high distribution rates and strong track records. ### SEE ALSO: The 19 Best ETFs for a Prosperous 2019

  • MoneyShow

    Three Blue Chip Funds at a Discount

    Ignore the doomsayers: 2019 is setting up to be a strong year for equities--and a great year for dividend investors like us, forecasts Michael Foster, closed-end fund expert and editor of the industry-leading CEF Insider.